Publications by authors named "Rory Sallach-Ruma"

Article Synopsis
  • The study assessed the effectiveness and financial impact of transitioning patients from intravenous (IV) to oral (PO) antimicrobial treatments at a Midwest US academic medical center.
  • It found that patients who weren’t converted to PO were more likely to be white and had a higher expected risk of mortality compared to those who were converted.
  • The study identified potential cost savings of $5,242 from successful conversions and an additional $8,805 in missed savings from not converting eligible doses, highlighting the need for more attention to antimicrobial conversion opportunities.
View Article and Find Full Text PDF

Inappropriate use of antimicrobial agents could result in antimicrobial resistance that could impact clinical cure outcomes (by increasing morbidity in terms of increased adverse events and risk of secondary and hospital-acquired infections and mortality) and increase costs to health care institutions. Thus, appropriate antimicrobial use has become vital for balancing patient safety and costs and is therefore a focus for health care institutions. This is often achieved through efforts of antimicrobial stewardship programs that include intravenous to oral conversion initiatives with clinical pharmacists playing an instrumental role in their development and implementation with medical staff approval.

View Article and Find Full Text PDF